Netherlands· NL-6f08562690e0
Vantobra 170 mg, verneveloplossing
A tobramycin product containing tobramycine, registered in Netherlands by PARI PHARMA GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tobramycin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB01 (tobramycin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tobramycin · ATC J01GB01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tobramycin costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tobramycin · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$98.67
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TOBRAMYCINE
- Manufacturer
- PARI PHARMA GmbH
- Country
- Netherlands (NL)
- ATC code
- J01GB01
- ATC class
- Tobramycin
- Defined daily dose
- 0.3 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1350
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for tobramycin.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tobramycin · interactions on record
191 records
- 29 severe
- 62 moderate
- 2 minor
- 98 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tobramycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVantobra 170 mgPARI Pharma
- SwedenVantobra 170 mg Lösning för nebulisatorPARI Pharma GmbH
- FinlandVantobraPARI Pharma GmbH
- IcelandVantobraPARI Pharma GmbH
- PolandVantobraPARI Pharma GmbH
- IrelandVantobra 170 mg nebuliser solutionPARI Pharma GmbH
- SpainVANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADORPari Pharma Gmbh
- United StatesBETHKISChiesi USA, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Czechia · Bramitob, Tobramycin Vioser
- Germany · Bramitob, Gernebcin
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Norway · Bramitob, Nebcina
- Poland · Bramitob, Tobramycin Via Pharma
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b4854b0-cf37-42cc-9a6b-0f1e37e22654 GET /v1/drugs/4b4854b0-cf37-42cc-9a6b-0f1e37e22654?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Verneveloplossing",
"route": "Inhalatie",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vantobra-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tobramycin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123617",
"excipients": [
"CALCIUMCHLORIDE 2-WATER (E 509)",
"MAGNESIUMSULFAAT 7-WATER (E 518)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZWAVELZUUR (E 513)"
],
"substances": [
"TOBRAMYCINE"
],
"leaflet_url": null,
"authorised_at": "2019/02/18",
"procedure_number": "EMEA/H/C/005086",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1350",
"additional_monitoring": "N"
}See everything about tobramycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.